Scarica l'app Stockscreener
10.93
267.99%
7.895
Precedente Chiudi:
$3.03
Aprire:
$8.27
Volume 24 ore:
61.49M
Relative Volume:
56.36
Capitalizzazione di mercato:
$6.50M
Reddito:
-
Utile/perdita netta:
$-5.00M
Rapporto P/E:
-9.50
EPS:
-1.15
Flusso di cassa netto:
$-3.85M
1 W Prestazione:
+264.38%
1M Prestazione:
+231.98%
6M Prestazione:
+37.10%
1 anno Prestazione:
-46.91%
Intervallo 1D:
$6.32
$11.80
Intervallo di 1 settimana:
$2.8161
$11.80
Portata 52W:
$2.35
$26.18
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
Nome
Protagenic Therapeutics Inc
Settore
Industria
Telefono
(212) 994-8200
Indirizzo
149 FIFTH AVENUE, NEW YORK
Confronta PTIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
11.01 | 1.64M | 0 | -5.00M | -3.85M | -1.15 |
|
ONC
Beigene Ltd Adr
|
231.20 | 25.21B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
436.04 | 112.83B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.3045 | 40.72M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.60 | 62.15B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.56 | 5.75B | 0 | -153.72M | -103.81M | -2.00 |
Protagenic Therapeutics Inc Borsa (PTIX) Ultime notizie
PTIX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Protagenic Therapeutics, Inc. Is Fair to Shareholders - Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXNM Energy, Inc. (NYSETXNM), Servotronics, Inc. (NYSE AmericanSVT), Protagenic Therapeutics, Inc. (Nasdaq – - TradingView
Protagenic Therapeutics stock soars on merger to create Neuroactive Biopharmaceutical company - Investing.com UK
Protagenic Therapeutics Skyrockets on Merger with Phytanix Bio: A Biotech Powerhouse in the Making? - RagingBull
Protagenic Therapeutics Completes Acquisition of Phytanix Bio - TipRanks
Protagenic Therapeutics merges with Phytanix Bio in all-stock deal By Investing.com - Investing.com India
Pre-market Movers: HCTI, PTIX, BCLI, AFMD... - RTTNews
Protagenic Therapeutics Enters Share Exchange Agreement With Alterola And EMC2SEC Filing - marketscreener.com
Protagenic Therapeutics (PTIX) Announces Merger with Phytanix Bio | PTIX Stock News - GuruFocus
Protagenic Therapeutics merges with Phytanix Bio in all-stock deal - Investing.com
Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic - GuruFocus
Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders - FinancialContent
Why Quantum Computing Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Protagenic Therapeutics, Inc.\new SEC 10-Q Report - TradingView
Pre-market Movers: CNSP, XLO, PLRZ, SGMO... - RTTNews
Performance Tech stock hits 52-week low at $0.4 - MSN
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
PTIXProtagenic Therapeutics Inc Latest Stock News & Market Updates - Stock Titan
Protagenic Therapeutics Inc (PTIX) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com
Protagenic Therapeutics Announces Reverse Stock Split - TipRanks
Protagenic Therapeutics announces 1-for-14 reverse stock split - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Protagenic Takes Bold Step: 1-for-14 Reverse Split Aims to Preserve Nasdaq Listing - Stock Titan
Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split - The Globe and Mail
Stock Surge: Protagenic Therapeutics Inc (PTIX) Closes at 0.23, Marking a -9.20 Increase/Decrease - DWinneX
Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th - ACCESS Newswire
Stock Market Recap: Protagenic Therapeutics Inc (PTIX) Concludes at 0.28, a 0.69 Surge/Decline - DWinneX
PTIX stock touches 52-week low at $0.25 amid sharp annual decline - MSN
Protagenic Therapeutics stockholders approve reverse split authority - Investing.com Australia
Protagenic Therapeutics stockholders approve reverse split authority By Investing.com - Investing.com South Africa
What Did We Note About Insider Trading At Protagenic Therapeutics Inc (NASDAQ: PTIX)? - stocksregister.com
Dow Tumbles 1,100 Points; US Economy Adds 228,000 Jobs In March - Benzinga
Dow Tumbles Over 1,100 Points; US Initial Jobless Claims Fall - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Protagenic Therapeutics, Inc.\new SEC 10-K Report - TradingView
PTIX stock plunges to 52-week low, hitting $0.23 - Investing.com India
PTIX stock plunges to 52-week low, hitting $0.23 By Investing.com - Investing.com Australia
Why Braze Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Benzinga
CoreWeave, Inc. (CRWV) Stock Price, News, Quote & History - Yahoo Finance
Protagenic Therapeutics (NASDAQ:PTIX) Stock Price Down 6.5% – Here’s Why - Defense World
BDSX Shrinks Loss With Revenue Growth, ALLR Plans $5Mln Share Buyback, What's The Buzz At PTIX? - RTTNews
PTIX stock plunges to 52-week low, hitting $0.25 By Investing.com - Investing.com Canada
Protagenic Therapeutics adjusts stock option prices By Investing.com - Investing.com South Africa
Protagenic Therapeutics adjusts stock option prices - Investing.com India
Protagenic Therapeutics Reprices Stock Options at Annual Meeting - TipRanks
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
PTIX’s Market Whiplash: -23.55% YTD Decline, -25.97% Plunge in 30 Days - The InvestChronicle
Stock Market Recap: Protagenic Therapeutics Inc (PTIX) Concludes at 0.37, a 11.82 Surge/Decline - The Dwinnex
Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Protagenic Therapeutics Inc (PTIX) Shares Plummet Below 1-Year High - The News Heater
Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Sees Significant Decrease in Short Interest - Defense World
Protagenic Therapeutics Inc Azioni (PTIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.88%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):